These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 9225141

  • 1. p53 mutation and protein alteration in 50 gliomas. Retrospective study by DNA-sequencing techniques and immunohistochemistry.
    von Eckardstein K, Gries H, Bolik E, Cervós-Navarro J, Tschairkin IN, Patt S.
    Histol Histopathol; 1997 Jul; 12(3):611-6. PubMed ID: 9225141
    [Abstract] [Full Text] [Related]

  • 2. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
    Lang FF, Miller DC, Pisharody S, Koslow M, Newcomb EW.
    Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140
    [Abstract] [Full Text] [Related]

  • 3. Detection of a novel point mutation in the p53 gene in grade II astrocytomas by PCR-SSCP analysis with additional Klenow treatment.
    Chawengchao B, Petmitr S, Ponglikitmongkol M, Chanyavanich V, Sangruji T, Theerapuncharoen V, Hayashi K, Thangnipon W.
    Anticancer Res; 2001 Mar; 21(4A):2739-43. PubMed ID: 11724349
    [Abstract] [Full Text] [Related]

  • 4. Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products.
    Mashiyama S, Murakami Y, Yoshimoto T, Sekiya T, Hayashi K.
    Oncogene; 1991 Aug; 6(8):1313-8. PubMed ID: 1886708
    [Abstract] [Full Text] [Related]

  • 5. [Mutations of p53 gene in 41 cases of human brain gliomas].
    Cui W, Kong X, Cao HL, Wang X, Gao JF, Wu RL, Wang XC.
    Ai Zheng; 2008 Jan; 27(1):8-11. PubMed ID: 18184456
    [Abstract] [Full Text] [Related]

  • 6. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies.
    Watanabe K, Sato K, Biernat W, Tachibana O, von Ammon K, Ogata N, Yonekawa Y, Kleihues P, Ohgaki H.
    Clin Cancer Res; 1997 Apr; 3(4):523-30. PubMed ID: 9815715
    [Abstract] [Full Text] [Related]

  • 7. p53 protein alterations in adult astrocytic tumors and oligodendrogliomas.
    Nayak A, Ralte AM, Sharma MC, Singh VP, Mahapatra AK, Mehta VS, Sarkar C.
    Neurol India; 2004 Jun; 52(2):228-32. PubMed ID: 15269478
    [Abstract] [Full Text] [Related]

  • 8. Ethnicity delineates different genetic pathways in malignant glioma.
    Chen P, Aldape K, Wiencke JK, Kelsey KT, Miike R, Davis RL, Liu J, Kesler-Diaz A, Takahashi M, Wrensch M.
    Cancer Res; 2001 May 15; 61(10):3949-54. PubMed ID: 11358811
    [Abstract] [Full Text] [Related]

  • 9. Influence of p53 mutations on prognosis of patients with glioblastoma.
    Shiraishi S, Tada K, Nakamura H, Makino K, Kochi M, Saya H, Kuratsu J, Ushio Y.
    Cancer; 2002 Jul 15; 95(2):249-57. PubMed ID: 12124823
    [Abstract] [Full Text] [Related]

  • 10. Human gliomas with wild-type p53 express bcl-2.
    Alderson LM, Castleberg RL, Harsh GR, Louis DN, Henson JW.
    Cancer Res; 1995 Mar 01; 55(5):999-1001. PubMed ID: 7867012
    [Abstract] [Full Text] [Related]

  • 11. p53 gene mutation and protein accumulation during neoplastic progression in Barrett's esophagus.
    Bian YS, Osterheld MC, Bosman FT, Benhattar J, Fontolliet C.
    Mod Pathol; 2001 May 01; 14(5):397-403. PubMed ID: 11353048
    [Abstract] [Full Text] [Related]

  • 12. Prognostic impact of TP53 mutations and P53 protein overexpression in supratentorial WHO grade II astrocytomas and oligoastrocytomas.
    Peraud A, Kreth FW, Wiestler OD, Kleihues P, Reulen HJ.
    Clin Cancer Res; 2002 May 01; 8(5):1117-24. PubMed ID: 12006527
    [Abstract] [Full Text] [Related]

  • 13. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas.
    Put-Ti-Noi S, Petmitr S, Chanyavanich V, Sangruji T, Theerapuncharoen V, Hayashi K, Thangnipon W.
    Oncol Rep; 2004 Jan 01; 11(1):207-11. PubMed ID: 14654927
    [Abstract] [Full Text] [Related]

  • 14. Correlation of p53 immunoreactivity and sequencing in patients with glioma.
    Kyritsis AP, Xu R, Bondy ML, Levin VA, Bruner JM.
    Mol Carcinog; 1996 Jan 01; 15(1):1-4. PubMed ID: 8561860
    [Abstract] [Full Text] [Related]

  • 15. Brainstem gliomas--a clinicopathological study of 45 cases with p53 immunohistochemistry.
    Badhe PB, Chauhan PP, Mehta NK.
    Indian J Cancer; 2004 Jan 01; 41(4):170-4. PubMed ID: 15659871
    [Abstract] [Full Text] [Related]

  • 16. PTEN gene mutations are seen in high-grade but not in low-grade gliomas.
    Rasheed BK, Stenzel TT, McLendon RE, Parsons R, Friedman AH, Friedman HS, Bigner DD, Bigner SH.
    Cancer Res; 1997 Oct 01; 57(19):4187-90. PubMed ID: 9331072
    [Abstract] [Full Text] [Related]

  • 17. Mutation analysis of DKK1 and in vivo evidence of predominant p53-independent DKK1 function in gliomas.
    Mueller W, Lass U, Wellmann S, Kunitz F, von Deimling A.
    Acta Neuropathol; 2005 Mar 01; 109(3):314-20. PubMed ID: 15668788
    [Abstract] [Full Text] [Related]

  • 18. Molecular genetic analysis of p53 intratumoral heterogeneity in human astrocytic brain tumors.
    Ren ZP, Olofsson T, Qu M, Hesselager G, Soussi T, Kalimo H, Smits A, Nistér M.
    J Neuropathol Exp Neurol; 2007 Oct 01; 66(10):944-54. PubMed ID: 17917588
    [Abstract] [Full Text] [Related]

  • 19. p53 mutation, EGFR gene amplification and loss of heterozygosity on chromosome 10, 17 p in human gliomas.
    Jin W, Xu X, Yang T, Hua Z.
    Chin Med J (Engl); 2000 Jul 01; 113(7):662-6. PubMed ID: 11776043
    [Abstract] [Full Text] [Related]

  • 20. Higher frequency of p53 gene mutations in diffuse large B-cell lymphoma with MALT component.
    Tai YC, Tan JA, Peh SC.
    Pathol Int; 2004 Nov 01; 54(11):811-8. PubMed ID: 15533223
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.